During Tuesday’s morning session, Corcept Therapeutics shares down by 0.59%, currently priced at $79.35. Considering the current price, Robb’s 145,000 shares have a total value of $10,963,450.
Strategic Sale: Gary Charles Robb Decides To Exercise Options Worth $10.96M At Corcept Therapeutics
view original post